Corroborating these findings, the inhibition of NEDD4-1 through indole-3-carbinol (I3C) treatment decreased tumorigenicity and increased the chemosensitivity of TMZ-resistant GBM cells to TMZ [73]. This evidence concerns the gene NEDD4 and glioblastoma.